Table 2.
Pharmacokinetic parameters (mean ± s.d.; (range)) for R-and S-pindolol, markers of renal cation secretion in healthy subjects.
| Markers (M) study arm | Markers + Fluconazole (F + M) study arm | P value* | (95% CI of difference) | |||
|---|---|---|---|---|---|---|
| Parameter | R | S | R | S | R | S |
| Cmax | 32 ± 12 | 34 ± 12 | 34 ± 13 | 34 ± 10 | 0.464 | 0.812 |
| (µg l−1) | (14–46) | (16–48) | (16,58) | (19,49) | (−6,2.6) | (−4.8,3.8) |
| tmax (h) | 1.4 ± 0.6 | 1.4 ± 0.6 | 1.6 ± 0.7 | 1.6 ± 0.7 | 0.252 | 0.444 |
| (0.8–2.5) | (0.8–2.5) | (0.8,3.0) | (0.8,3.0) | (−0.62,0.14) | (−0.55,0.23) | |
| Ae | 1979 ± 790 | 2397 ± 808 | 2135 ± 868 | 2579 ± 892 | 0.229 | 0.232 |
| (mg) | (683–3024) | (784–3334) | (875,3444) | (1148,4329) | (−396,84) | (−462,100) |
| CL/F | 1005 ± 615 | 834 ± 402 | 820 ± 401 | 674 ± 154 | 0.101 | 0.131 |
| (ml min−1) n = 11 | (528–2388) | (416–1872) | (448,1768) | (434,862) | (−16,386) | (−31,352) |
| CLR | 204 ± 41 | 225 ± 55 | 190 ± 41 | 209 ± 60 | 0.394 | 0.270 |
| (ml min−1) n = 11 | (140–261) | (153–296) | (141,260) | (153,297) | (−17,45) | (−10,41) |
| CLuR (ml min−1) | 452 ± 92 | 499 ± 121 | 421 ± 92 | 465 ± 132 | 0.394 | 0.270 |
| n = 11 | (342–580) | (341–692) | (314,577) | (264,660) | (−38,100) | (−23,92) |
| CLfilt (ml min−1) | 53 ± 15 | 58 ± 19 | 0.423 | |||
| n = 11 | (35–84) | (34–92) | (−14–6) | |||
| Net CLsecr | 150 ± 49 | 171 ± 60 | 132 ± 45 | 152 ± 70 | 0.296 | 0.197 |
| (ml min−1) n = 11 | (91–203) | (69–253) | (66,225) | (33,253) | (−14.2,50.7) | (−8,47) |
Paired t-test: Markers (M) vs Markers + Fluconazole (F + M) study arms.